复方新诺明和利福平治疗儿童布鲁氏菌病6周或8周的疗效
Efficacy of cotrimoxazole and rifampin for 6 or 8 weeks of therapy in childhood brucellosis.
作者信息
Roushan Mohammad Reza Hasanjani, Mohraz Mino, Janmohammadi Nasser, Hajiahmadi Mahmood
机构信息
Department of Infectious Diseases, Yahyanejad Hospital, Babol, Iran.
出版信息
Pediatr Infect Dis J. 2006 Jun;25(6):544-5. doi: 10.1097/01.inf.0000219403.91975.ce.
From March 1998 to September 2001, 64 children and from October 2001 to December 2004, 66 children < or = 15 years with brucellosis in Babol, Iran, were treated with cotrimoxazole and rifampin for 6 or 8 weeks, respectively. Cure rate for 6 weeks was 89.1% and for 8 weeks it was 95.5%. Six weeks of therapy with cotrimoxazole plus rifampin is sufficient for treatment of childhood brucellosis.
1998年3月至2001年9月，伊朗巴博勒有64名15岁及以下患布鲁氏菌病的儿童，2001年10月至2004年12月，又有66名此类儿童，分别接受了为期6周或8周的复方新诺明和利福平治疗。6周治疗的治愈率为89.1%，8周治疗的治愈率为95.5%。复方新诺明加利福平治疗6周足以治愈儿童布鲁氏菌病。
Zotero 插件